We describe and evaluate a regression tree algorithm for finding subgroups with differential treatments effects in randomized trials with multivariate outcomes. The data may contain missing values in the outcomes and covariates, and the treatment variable is not limited to two levels. Simulation results show that the regression tree models have unbiased variable selection and the estimates of subgroup treatment effects are approximately unbiased. A bootstrap calibration technique is proposed for constructing confidence intervals for the treatment effects. The method is illustrated with data from a longitudinal study comparing two diabetes drugs and a mammography screening trial comparing two treatments and a control.
Introduction
Interest in precision medicine (also known as personalized medicine and tailored therapeutics), where therapies are customized for individual patients based on their genetic and other characteristics, is drawing more attention to regression tree methods designed to identify subgroups with differential treatment effects from randomized trials. The interaction trees [1] [2] [3] method selects splits that minimize p-values of interaction terms in models fitted to the nodes of the trees. The virtual twins [4] method estimates the treatment effect of each subject using a random forest [5] model and then fits a CART [6] tree to the estimated effects to obtain the subgroups. SIDES [7] finds multiple subgroups that optimize certain measures (such as p-values or treatment effect sizes). QUINT [8] searches for subgroups that balance effect size and subgroup size. Although obvious and seemingly natural, algorithms that search for splits that optimize one or more criteria have two undesirable consequences: biased variable selection (all things being equal, some variables are more likely than others to be selected to define the subgroups) and biased estimates of subgroup effects (estimated differences in treatment effects between subgroups are overly large). Loh et al. [9] extended the GUIDE [10] [11] [12] approach to find subgroups without these biases. Except for Su et al. [3] , the methods are applicable to a single outcome variable only. The purpose of this article is to further extend the GUIDE subgroup identification approach to multivariate outcome variables.
To illustrate, consider a multi-center, randomized double-blind trial on the long-term efficacy and safety of Pioglitazone versus Gliclazide in patients with Type 2 diabetes mellitus that is inadequately controlled by diet alone [13] . Gliclazide increases the amount of insulin produced by the pancreas while Pioglitazone is an 'insulin sensitizer'-it improves the ability of the body to use insulin. The trial consisted of 1249 subjects between 35 and 75 years old with HbA1c between 7.5% and 11.0% and for whom diet was prescribed for at least 3 months. Each subject was randomized to a 52-week treatment period consisting of a 16-week forced-titration period to a maximum dose and a 36-week maintenance period at the maximum tolerated dose of the drug. The treatments were 80mg Gliclazide (625 subjects), 30mg Pioglitazone (114 subjects), and 45mg Pioglitazone (510 subjects). Twenty-three baseline variables were measured for each subject. There are nine outcome variables, namely, HbA1c at 0, 4, 8, 12, 16, 24, 32, 42 , and 52 weeks. The primary efficacy endpoint is change from baseline HbA1c. Combining the subjects given 30 and 45 mg Pioglitazone into one 'Pioglitazone' group gives 747 subjects (383 and 364 in the Pioglitazone and Gliclazide groups, respectively) with complete HbA1c values at all time points. Table I gives the names, definitions, and numbers of missing values of the predictor variables, and Figure 1 plots the group mean HbA1c values over time. Gliclazide appears to be better, on average, than Pioglitazone in lowering HbA1c throughout. But is there a subgroup for which Pioglitazone might be better for at least some time points? Figure 2 shows one possible subgroup, defined by HOMA-B > 23.90 and FastBG > 10.85, where Pioglitazone appears to control HbA1C better than Gliclazide after 25 weeks. 
One outcome variable
A unique feature of Gi is how it selects a split of the data in each node of a tree. Let Y denote the (single) outcome variable and Z a treatment variable taking G nominal values z = 1, 2, … , G. Let X i be a predictor variable. At each node t of the tree, a lack-of-fit F test is used to select an X i to split the data in t. If X i is an ordinal variable, the test temporarily converts it into a two-group categorical variable H i by splitting its values at the mean. If X i is categorical, then H i = X i with each category forming a group. If there are missing values in X i , a 'missing' group is added. This allows observations with missing values to be included for variable selection at every node.
We fit the additive model
to the data in t and obtain its F-statistic F i and p-value p i for the 'pure error' lack-of-fit test [14, Sec. 4.3] . Our goal is to select the most significant X i to split the data in the node. The value of p i can be tiny and hard to compute if X i has a large interaction with Z. To avoid its computation in such situations, we transform the F i statistics to 1-df chi-squared quantiles and select the X i with the largest chi-squared instead. Let i and i be the numerator and denominator dfs of F i , and let i and 2 i denote the mean and variance, respectively, of the central F distribution with these dfs. Transformation of F i to chi-squared is carried out in two parts.
(1) If F i is not extremely large (specifically, i < 10 and F i < 3000 i + i or i ⩾ 10 and F i < 150 i + i ), compute p i directly from the F distribution and then compute the (1 − p i )-quantile 2 1 (i) of the chi-squared distribution with 1 df. (2) Otherwise, use a two-step approximation:
Then 2 1 (i) is approximately the (1 − p i )-quantile of a chi-squared distribution with 1 df. The result is obtained by combining two approximations in Wilson and Hilferty [16] (see [17, p. 427] ). If i = 1, then w 1 = w 2 = 2 i and 2 1 (i) = 2 i , and this step is not needed.
Part 2(b) improves upon a earlier approximation used in Loh [11] and Loh et al. [9] . Let X * be the variable with the largest value of 2 1 (i). The data in t are partitioned into left and right child nodes by a split on X * of the form 'X * ⩽ c' if X * is ordinal or 'X * ∈ C' where C is a subset of the values of X * if it is categorical. The best split is found by minimizing S L + S R , where S L and S R are the sums of the squared residuals of the treatment-only model EY = 0 + ∑ z z I(Z = z) fitted independently to the left and right child nodes. Only splits that yield child nodes with all treatment levels present are considered. The whole procedure is applied recursively at each node until the number of observations is below a threshold (e.g., 5% of the sample size). Then, the tree is pruned using the CART method, and 10fold cross-validation (CV) is used to find the smallest CV mean squared error MSE 0 among the subtrees. The smallest subtree with CV MSE within half a standard error of MSE 0 is selected.
What happens if there are missing X * values in the training sample or in a future sample to be predicted? Following [9, 11] , we send all missing X * values to the same child node. Let NA denote the missing value code, and let t L denote the left child node of a split of t on X * . If X * is an ordinal variable, the minimization of S L + S R is over c for t L of the form (i) 'X * = NA', (ii) 'X * ⩽ c and X * = NA', and (iii) 'X * ⩽ c and X * ≠ NA'. If X * is categorical, its missing values are treated as another category. Other algorithms use different methods to deal with missing values. CART uses surrogate splits, but they do not give better predictions. Another approach is imputation of the missing values using, for example, regression of X * on the other X variables, but this may not work well if the other X variables have missing values too [18] . There is one esthetic advantage to sending all missing values to one child node: the split can be displayed compactly in a tree diagram. To indicate that missing values, go to the left child node in a split on an ordinal X; we add an asterisk subscript to the inequality sign, for example, 'X ⩽ * c'. If missing values, go to the right child node; we denote the split simply as 'X ⩽ c'. See Figure 3 later for an example.
Multiple outcome variables
The method for one outcome can be extended to more than one outcome by applying it to one Y j at a time. For each X i , we now have a Wilson-Hilferty 1-df chi-squared value, 2 1 (i, j) say, for each Y j . Let q i = ∑ j 2 1 (i, j) be the sum of the chi-squared values over the outcomes. Let X * be the X i for which q i is maximum. Then, for each binary split of the data on X * in t, we fit the model
to the data in the two subnodes and choose the split that minimizes the total sum of the squared residuals, where the total is over the outcomes and the two subnodes. (We considered using max j 2 1 (i, j) in place of q i but the results are not as good. Besides, a sum of chi-squared has advantages in importance scoring of variables, a topic not discussed here.)
The power and versatility of this approach can be improved with two additions:
Local linear transformations. One weakness of the technique is that it ignores correlations among the Y j . A standard solution is to transform (Y 1 , Y 2 , …) to another coordinate system using, for example, principal component analysis (PCA) or linear discriminant analysis (LDA) with Z as the class variable. But this may be ineffective if the correlation structure is not constant over the predictor variable space. A better solution is to perform PCA or LDA independently at each node t. For PCA, this is achieved by replacing the Y j values with their principal components at the node in the computation of the lack-of-fit tests. The split on the selected variable X * is found as before, that is, the sums of squared residuals are based on the untransformed Y j values. The procedure for LDA is the same, except that the Y j values are replaced by the canonical variates (discriminant coordinates) in the computation of the lack-of-fit tests.
Weights. The Y j may be measured on different scales; they may not be equally important, or they may measure different outcomes (e.g., Y 1 is a measure of efficacy and Y 2 a measure of safety). If they are measured on different scales, they may be normalized to have equal sample variance prior to analysis. If they are not equally important or they measure different outcomes, a weighted total sum of squared residuals may be used to search for the best split on X * , with weights chosen by the user.
Algorithm 1 presents the basic procedure in pseudocode.
The result in Figure 2 is obtained with LDA transformation of the observed HbA1c values at each node. The corresponding results without any transformation and with PCA transformation are shown in Figures 3 and 4 , respectively. The model with PCA is a subtree of the one with LDA. All three tree models split on HOMA-B at some point. Figure 2 is easiest to interpret based on our understanding of how the drugs work. HOMA-B is a measure of beta cell function, which is the ability to produce insulin. Low values of HOMA-B indicate worse beta cell function. Node 2 in Figure 2 contains subjects with poor beta cell function (less insulin production). Gliclazide works well for these patients because they are insulin deficient. Pioglitazone does not work as well because these patients do not have much insulin in their bodies; making them more sensitive to insulin may not be the best solution. Stimulation of the deteriorating beta cells to produce additional insulin may instead accelerate the decline of beta cell function. At intermediate node 3, where patients have relatively good beta cell function and often good amounts of insulin, Pioglitazone is expected to work better. The split there on FastBG is meaningful. Patients with high FastBG (node 7) often have more insulin in their body conditional on the same beta cell function. Pioglitazone seems to work better for them after 20 weeks. One may wonder why node 3 is split on FastBG instead of FastInsulin. The answer may be because high FastBG is indicative of greater potential for decreasing blood glucose. Therefore, FastBG is an excellent biomarker for high insulin as well as potential for improvement. Figure 5 shows a plot of FastBG versus HOMA-B for the whole data set. It is less easy to explain why ALT is chosen to split the root node in Figure 3 . The split is not counter intuitive, however, because ALT is a biomarker for liver function, with large values indicative of liver damage. Gastaldelli et al. [19] found that Pioglitazone works by reducing liver glucose synthesis, and Harris [20] found that the latter is associated with ALT. Using ALT as a predictor, however, is complicated by the fact that men and women have different normal ranges (male <43, female <34) and by gender not being among the variables reported in the data.
Simulation results on bias
A tree model needs three essential properties for interpretability: (i) unbiased variable selection; (ii) unbiased estimates of treatment means in the nodes; and (iii) confidence intervals for the treatment means. This section uses simulations to show that the proposed method has the first two properties. The third property is addressed in Section 4. Table II . Estimated probabilities of variable selection from 10,000 simulation iterations. 
Bias in variable selection
A basic requirement for model interpretation is that the algorithm selects variables to split the nodes without bias. That is, if all the predictor variables are independent of the outcomes, each should be selected with equal probability. CART [6] and algorithms that adopt its paradigm are known to be biased in selecting variables that allow more splits [10, 11, 21, 22] . There are two consequences to biased selection. One is increased likelihood that the subgroups are defined by less relevant variables, which undermines confidence in the conclusions. Another is that if splits on less relevant variables occur sufficiently often in a tree, pruning may remove many of the splits, which reduces the power of the procedure. To see whether our method is unbiased, we carried out two simulation experiments where the predictor variables are independent of the longitudinal outcomes. Let M(m) denote the multinomial distribution with m equi-probable cells, U(c, d) the uniform distribution on the interval (c, d), E( ) the exponential distribution with mean , and N( , 2 ) the normal distribution with mean and variance 2 . Let X 1 , X 2 , …, X 5 , and Z be mutually independent predictor and treatment variables with distributions X 1 ∼ M(2), (2) . Let Y ij denote the outcome for subject i at time j (j = 1, 2, … , 10). The first experiment employs a linear mean function and the second a quadratic one that mimics the mean function of the diabetes data:
Here b 1i ∼ U (3, 4) , b 2i ∼ U(0, 1), and ij ∼ N(0, 1) are mutually independent, representing random subject effects and measurement error, respectively. Two hundred sample vectors (X 1 , X 2 , … , X 5 , Y, Z) were repeatedly simulated, and the frequency that each X variable was selected to split the root node of the tree was recorded. The results in Table II show the average frequencies over 10,000 simulation trials; all are within three simulation standard errors of 0.20, the target value if variable selection is unbiased.
Bias in treatment effects
It is equally important for the estimated treatment mean t (z) for Z = z in the terminal nodes t be unbiased. Many algorithms, such as SIDES [7] and QUINT [8] , search for split points that optimize treatment Copyright effects between nodes. As a result, they tend to yield overly optimistic estimates that require subsequent bias adjustment. The difficulty with evaluating the bias of the treatment means in a node t of a tree is that t is not fixed but is a function of the training sample. Loh et al. [9] instead estimate the average bias of the means, where the average is over all terminal nodes t. They show by simulation that the bias is remarkably small. Their results are, however, limited to a single outcome and categorical predictor variables with three categories each.
Given a node t in a tree T and Z = z, let j (z, t) = EY j denote the mean of Y j for treatment z in t, and let j (z, t) be its estimate. LetT denote the set of terminal nodes of T and |T| be its number of terminal nodes. Define the average error over t ∈T for outcome Y j and treatment level z as
The average bias is j (z) = ED j (T, z) and average relative bias is j (z) = ER j (T, z). To see whether they are close to 0, we carried out the following simulation experiment modeled after the diabetes data. Set = 6 and = 1 = 0.5. Let = (X 1 , X 2 , … , X 23 ) be the variables listed in Table I , with X 1 and X 2 being HOMA-B and FastBG, respectively (see Figure 5 for their joint distribution). Let D = { 1 , 2 , … , n } denote the set of 1077 vectors in the diabetes data with nonmissing HOMA-B (172 of the 1249 subjects are missing HOMA-B; none is missing FastBG; Table I ). Using D as the simulation population, randomly
and its mean conditional on ( * , Z * ): *
The estimation error and relative error are d * j (z, t * ) =̂ * j (z, t * ) −̄ * j (z, t * ) and r j (z, t * ) = d * j (z, t * )∕̄ * j (z, t * ), respectively. The corresponding average error and average relative error over
Repeating the simulation many times and averaging the values of D * j (z) and R * j (z) over the number of trials gives estimates of the average bias j (z) and average relative bias j (z). Tables III and IV give the results based on 1000 simulation trials for samples of size n = 100, 500, and 1000, with m additional independent U(0, 1) noise variables, for m = 0, 50, and 100 (the number of X i without noise variables is 23). The bias and relative bias tend to decrease as sample size increases. For n = 1000, more than half are within three simulation standard errors of zero. Further, the results seem to be relatively unaffected by the number of noise variables.
Bootstrap calibrated intervals
Without confidence intervals to indicate the accuracy of the treatment means, graphs such as that in Figure 1 are not as informative as those in Figures 2-4 . Construction of confidence intervals in the terminal nodes of a tree has been a challenging problem, however, since the first regression tree algorithm [23] appeared more than 50 years ago. The difficulty is again due to the terminal nodes being a function of the training data. As a result, the quantities being estimated, such as the node treatment effects, are random. In the context of genome-wide association studies, the problem has been called 'selective Table III . Estimated average bias j (z) of treatment means in 1000 simulation trials with standard errors in parentheses; n is sample size and |T| is average number of terminal nodes. inference' [24] . Loh et al. [9] describe a method to obtain bootstrap confidence intervals for the case of a single outcome variable. It does so by estimating the standard error of the treatment effects with the standard errors of bootstrap estimates of the corresponding population parameters. Despite simulation results demonstrating its effectiveness, the procedure is unintuitive and lacks justification. We propose a simpler and more intuitive method based on bootstrap calibration [25] , which is briefly explained as follows. Suppose for the moment that there is only one outcome variable, no treatment variable, and t is pre-specified. Given a nominal , a naïve 100(1 − )% interval for the mean outcome
Here, denotes a random sample of observations, y t , s t , and n t its sample mean, standard deviation and sample size in t, and = n t − 1. Let F denote the population from which the data are obtained, and let ( , F, t) = P F { t ∈ I( , , t)} denote the true coverage probability of the interval. Typically, ( , F, t) → 1 − as n t increases if t is fixed. Bootstrap calibration attempts to increase the rate of convergence. LetF denote the empirical distribution of . Using a computer or otherwise, draw bootstrap samples of size n t fromF. For each bootstrap sample * , letȳ * weak conditions, the true coverage probability of I( ,̂, t) converges to 1− an order of magnitude faster than the nominal interval I( , , t).
One modification is needed to extend this technique to the nodes of a tree model. Because the tree and its nodes vary from one sample to another, it is not possible to calibrate for the coverage probability of one particular node. Instead, we calibrate to improve the average coverage probability over all the nodes of a tree. Let̄( , F) = E{|T| −1 ∑ t∈T ( , F, t)} denote the expected average coverage probability over the terminal nodes of a tree T. Draw bootstrap samples B times fromF as before to obtain the bootstrap estimate of average coverage probabilitȳ( ,F). Do this for a grid of k values 1 < 2 < … < k , with k being the desired level, gettinḡi =̄( i ,F), i = 1, 2, … , k. 
i . The calibrated̂is the value such that̄(̂,F) = 1 − , that is,̂= b −1 , and the bootstrap interval in each node is recalculated witĥin place of . The pseudocode in Algorithm 2 finds onêfor all outcomes by averaging the coverage probabilities over the outcome variables and the terminal nodes. It can be modified to find a separatêfor each outcome.
To evaluate the accuracy of the bootstrap calibrated intervals, we carried out a simulation experiment using the setup in Section 3.2 as follows. Let * = ( X * 1 , X * 2 , … ) denote a random sample drawn with replacement from the diabetes data set D, with X 1 and X 2 being HOMA-B and FastBG, respectively. For each * , simulate mutually independent Z * = 0, 1 with P(Z * = 1) = 0.50, b 1 U(0.1, 0. 2), and * j ∼ N(0, 2 ) (j = 1, 2, … , 9), with = 1 = 0.50. The simulated jth outcome is
Then, construct a naïve (i.e., uncalibrated) and a bootstrap calibrated interval for the treatment mean in each node. See Algorithm 3 for the simulation details. Table V gives the coverage probabilities of the 95% naïve and bootstrap intervals averaged over the nine outcomes for n = 100, 500, and 1000, with m = 0, 50, and 100 independent U(0, 1) noise variables added. The results are based on 1000 simulation trials with B = 25 bootstrap iterations per trial (the real data examples employ B = 100). The coverage probabilities of the bootstrap intervals are clearly much closer to the nominal value of 0.95.
Mammography screening
Algorithms for subgroup identification that depend on estimation of a treatment-covariate interaction are typically applicable to treatments with two levels only. Our next data set has two outcome variables and a three-level treatment variable. CAPE [27] is a randomized controlled trial designed to determine whether two interventions (DVD or Phone) are more efficacious than a control treatment at promoting Logistic regression, applied to each outcome separately on the subjects with complete observations, finds no significant differences between DVD and control, or between phone and control, although there is a significant interaction for the 6-month screening outcome. For women in the low (⩽30K) or middle (30-75K) income categories, DVD is significantly more efficacious than control, and for women in the highest income category (⩾75K), DVD is significantly less efficacious than control. There are also some significant interactions between intervention groups and covariates, such as baseline belief scale scores, for the 21-month outcome. These tests, however, are carried out by testing 2 × 2 interactions in logistic regression without controlling for multiplicity.
We first analyze the data using the subset of 1493 subjects with both 6-month and 21-month outcomes. Figure 6 shows our regression tree model if the outcome variables are not transformed. The corresponding results with PCA and LDA transformations of the outcome variables at each node are shown in Figures 7  and 8 , respectively. Variables sf12gh (general health score) and yearmam (number of years had a mammogram in past) appear in all three trees. Variable opt (optimism scale score) appears in the latter two trees, and fear (perceived fear scale score) appears in the first and third trees. The split points are similar across trees. Mean outcomes are clearly lower if the number of years a subject had a mammogram in the past is 0 or 1 (yearmam ⩽ 1).
The subgroup {sf12gh > 72, fear ⩽ 18, yearmam ⩽ 1} in Figure 6 shows statistically significant differential treatment effects. Subjects in the DVD treatment group have the lowest average response rates, and according to the bootstrap confidence intervals, the rates are significantly lower than those for phone. But the rates for phone are not significantly higher than those for control. This subgroup is quite small, however, with 117 subjects.
The results are slightly different in Figure 7 , where the subgroup showing statistically significant differential treatment effects is {opt > 13, sf12gh > 72, yearmam ⩽ 1}. The DVD treatment group still has the lowest average response rates, and they are significantly lower than those for phone. But the DVD rate at 21 months is also significantly lower than that for control. The subgroup sample size is 264.
The subgroup with statistically significant differential treatment effects in Figure 8 is {opt > 13, sf12gh > 72, fear ⩽ 21, yearmam ⩽ 1}. It is a subset of the subgroup in Figure 7 . Here, the response rates for DVD are not significantly lower than those for control, but this may be due to the sample size being smaller at 143.
Missing outcomes
Although we have used only subjects with observations in all Y j variables so far, our method can include subjects who are missing some (but not all) Y j . Recall that split variable selection at each node is achieved by performing a lack-of-fit test on one Y j at a time. Therefore, each test can utilize all subjects with nonmissing values in that Y j , and the same subjects can be used to fit model (1) in the child nodes for Copyright An interesting question is whether one should use this more general approach or restrict the models to subjects with complete outcomes. Certainly, restricting to completely observed outcomes makes implicit assumptions about the reasons for the outcomes being missing. If we use all 1249 subjects with at least one outcome in the diabetes data, the pruned tree has no splits. On the other hand, if we use all 1638 subjects with one or more outcomes in the mammography data, we obtain the tree in Figure 9 . It is the same as the tree (Figure 6 ) based on the subset of subjects with complete outcomes. The node treatment means differ slightly between the trees, due to different numbers of observations; compare, for example, the treatment means at the node {sf12gh >72, fear >18}. Because the model is the same with and without excluding subjects with incomplete outcomes, the result seems to suggest that the outcomes are missing at random. These two examples show that it is useful in practice to analyze the data with and without the subjects with incomplete outcomes. To our knowledge, the interaction trees approach [3] is currently the only other method that can deal with incomplete outcomes. It uses the CART paradigm, which searches all split points on all split variables at each node. For longitudinal outcomes with binary treatment Z = 0 or 1, interaction trees fits a GEE [28] model with mean function
to the data in each node and each predictor X k . Here, A k = (−∞, c] if X k is ordinal and is a subset of the levels of X k if it is categorical. The set A k that minimizes the p-value of the test that 3 = 0 is selected to split the node. One advantage of this approach is that correlations between the Y j are easily incorporated through specification of a correlation matrix. Another advantage is that subjects can have incomplete outcomes. But it also has disadvantages. The most obvious is the computational cost of fitting many GEE models. An ordinal variable X k with m unique values generates (m−1) split sets A k . A categorical variable X k with m levels generates (2 m−1 − 1) split sets. Therefore, the number of GEE models to be fitted at each node is linear or exponential in m for each X k . In practice, specification of the correlation matrix is nontrivial. Su et al. [3] use a matrix with constant correlation, but correlations between outcomes far apart in time may be weaker than those nearer together, and the correlations in one child node may differ from those in its sibling node. Further, Equation (5) assumes that the interaction coefficient 3 is constant over j. This may not be realistic if the number of outcome variables is large. Finally, as with all algorithms that rely on direct optimization, the approach is susceptible to selection bias, because variables that allow more splits have an inherent advantage to be selected. 
Concluding remarks
We have described a technique to fit regression tree models that identify subgroups with differential treatment effects from randomized trials with multivariate outcome variables. To our knowledge, it is the first (tree or non-tree) subgroup procedure to accept two or more outcomes simultaneously, to allow missing values in predictor and outcome variables, to allow treatments with more than two levels, and to possess unbiased variable selection and approximately unbiased estimates of treatment effects in the subgroups. Further, if outcomes are completely observed, it can take advantage of local dependencies among outcome variables by employing PCA or LDA transformations at each node of the tree. The examples indicate that either PCA or LDA may be better than no transformation, but the best solution is probably data dependent. In our experience, having more than one solution is often desirable in practice, because they allow the user to apply subject matter knowledge to compare them. The machine learning approach to subgroup identification typically treats the problem as optimization: search for the subgroups that have the greatest observed differential treatment effects. This necessarily produces biased estimates of the effects. Our two-step method escapes this consequence by taking a different tack. The first step ensures that, with high probability, the right variable is chosen to split the node without selection bias. The second step finds the split that fits the data in both subnodes best, without directly maximizing the observed treatment effect in one at the expense of the other. It is natural to wonder if intentionally avoiding the split that maximizes the observed differential treatment effect is the best strategy. The answer is certainly yes, if unbiased estimates are desired. But will this strategy find the correct subgroup? If the treatment effect is a smooth monotone function of a continuous variable X, then, there is no subgroup that is 'correct' without additional qualification. For example, suppose the true Copyright model producing the data is EY = 0 + f (X)I(Z = 1), where f (x) is strictly increasing in x. Then, for any c, the subgroup {X > c} has a larger treatment effect than its complement {X ⩽ c}. Larger values of c yield subgroups with larger treatment effects but they are correspondingly smaller in size. Given that no correct subgroup exists in this case, we are left with two choices: (i) find the subgroup with the maximum observed differential treatment effect and suffer the consequences of biased estimates; or (ii) settle for a subgroup with observed treatment effects that may be less than maximal but that yields approximately unbiased effect estimates. Many methods take the first option; we take the second one here.
There are numerous 'engineering choices' that can potentially affect the performance of our algorithm. One is the two-group conversion of an ordinal variable X into a categorical variable H in the lack-offit test. If the sample size at the node is large, this may cause some loss of power in selecting the best X. We could avoid this by converting X into three or more groups, but as sample size decreases with partitioning, the groups will quickly have too few observations. An alternative is to start with a larger number of groups at the top levels of the tree and reduce them at the lower levels. Recall, however, that H already has three groups with dichotomization of X if the latter has missing values. Loss of information from dichotomization is often more than offset by the increase in power from having a missing-value group that admits all observations, especially if missingness is informative.
Our bootstrap calibration approach to confidence interval construction is independent of the subgroup identification algorithm. It can be used with any algorithm and applied to any naïve interval. There is no need to adjust or control for the multiplicity of tests in the search algorithm because all the steps are accounted for in the bootstrap procedure. If calibration is performed on the naïve t-interval, however, it is preferable for the effect estimates to be unbiased.
The tree algorithm discussed here is implemented in the GUIDE software available from www.stat. wisc.edu/~loh/guide.html. It also includes a parallel extension to multiple outcomes of the Gs option proposed in Loh et al. [9] .
